Core Viewpoint - The company announced the passing of its General Manager, Zhang Jianhui, due to illness, highlighting his significant contributions to the company's development since 2015 [1] Company Overview - Zhang Jianhui served as a major shareholder of the company or its predecessor, Jiangsu Jindike Biotechnology Co., Ltd., since 2015 and was appointed General Manager in October 2023 [1] - He held 5.6804 million shares, representing 4.61% of the company's total share capital [1] - The company confirmed that its operations remain normal following Zhang's passing [1] Management Transition - The board of directors has appointed Chairman Yu Jun to act as the General Manager temporarily [1] - The company will expedite the process of appointing a new General Manager in accordance with the Company Law of the People's Republic of China and its articles of association [1]
金迪克:总经理张建辉因病逝世